Search
Bioatla Inc
BCABAdd to Watchlist
3.300USD
-0.080-2.37%
Close 07-31 16:00（ET）Quotes delayed by 15 min
5.48MMarket Cap
LossP/E TTM
More Details of Bioatla Inc Company
BioAtla, Inc. is a clinical-stage biopharmaceutical company focused on developing antibody-based therapeutics for the treatment of solid tumor cancer. The Company’s product candidates include Mecbotamab vedotin (BA3011), Ozuriftabmab vedotin (BA3021), evalstotug (BA3071), and BA3182. Its lead product candidate, BA3011, is a conditionally active biologics (CAB) antibody-drug conjugate that targets AXL, which is a protein kinase receptor. The BA3071 is a potential therapeutic for multiple solid tumor types, including soft tissue and bone sarcoma, and non-small cell lung cancer. BA3021 is developing a CAB antibody drug conjugate directed against a receptor tyrosine kinase such as orphan receptor 2 (ROR2). BA3071 is a CAB anti-CTLA-4 antibody that is being developed as a therapeutic for multiple solid tumor indications. BA3182 is designed with an EpCAM binding domain and a CD3 binding domain, both binding domains with CAB activity (Dual-CAB), for the treatment of advanced adenocarcinoma.
Bioatla Inc Info
Ticker SymbolBCAB
Company nameBioatla Inc
IPO dateDec 16, 2020
CEOShort (Jay M)
Number of employees61
Security typeOrdinary Share
Fiscal year-endDec 16
Address11085 Torreyana Road
CitySAN DIEGO
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code92121
Phone18585580708
Websitehttps://www.bioatla.com/
Ticker SymbolBCAB
IPO dateDec 16, 2020
CEOShort (Jay M)
Company Executives of Bioatla Inc
Name
Name/Position
Position
Shareholding
Change
Dr. Jay M. Short, Ph.D.
Dr. Jay M. Short, Ph.D.
Chairman of the Board, Chief Executive Officer, Co-Founder
Chairman of the Board, Chief Executive Officer, Co-Founder
39.94K
+97.99%
Mr. Richard A. Waldron
Mr. Richard A. Waldron
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
6.87K
+98.01%
Dr. Eric L. Sievers, M.D.
Dr. Eric L. Sievers, M.D.
Chief Medical Officer
Chief Medical Officer
3.57K
+97.82%
Dr. Lawrence Steinman, M.D.
Dr. Lawrence Steinman, M.D.
Lead Independent Director
Lead Independent Director
1.57K
+98.60%
Dr. Mary Ann Gray, Ph.D.
Dr. Mary Ann Gray, Ph.D.
Independent Director
Independent Director
1.55K
+98.58%
Dr. Susan Moran, M.D.
Dr. Susan Moran, M.D.
Independent Director
Independent Director
1.05K
+98.85%
Mr. Scott A. Smith
Mr. Scott A. Smith
Director
Director
--
--
Mr. Christian Vasquez, CPA
Mr. Christian Vasquez, CPA
Chief Accounting Officer, Controller, Corporate Secretary
Chief Accounting Officer, Controller, Corporate Secretary
--
--
Mr. Edward L. (Eddie) Williams
Mr. Edward L. (Eddie) Williams
Independent Director
Independent Director
--
--
Ms. Sylvia Mcbrinn
Ms. Sylvia Mcbrinn
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Dr. Jay M. Short, Ph.D.
Dr. Jay M. Short, Ph.D.
Chairman of the Board, Chief Executive Officer, Co-Founder
Chairman of the Board, Chief Executive Officer, Co-Founder
39.94K
+97.99%
Mr. Richard A. Waldron
Mr. Richard A. Waldron
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
6.87K
+98.01%
Dr. Eric L. Sievers, M.D.
Dr. Eric L. Sievers, M.D.
Chief Medical Officer
Chief Medical Officer
3.57K
+97.82%
Dr. Lawrence Steinman, M.D.
Dr. Lawrence Steinman, M.D.
Lead Independent Director
Lead Independent Director
1.57K
+98.60%
Dr. Mary Ann Gray, Ph.D.
Dr. Mary Ann Gray, Ph.D.
Independent Director
Independent Director
1.55K
+98.58%
Dr. Susan Moran, M.D.
Dr. Susan Moran, M.D.
Independent Director
Independent Director
1.05K
+98.85%
FAQs
Who are the top five shareholders of Bioatla Inc?
The top five shareholders of Bioatla Inc are: Dr. Jay M. Short, Ph.D.
How many institutions hold shares of Bioatla Inc (BCAB)?
As of 2026Q1, 189 institutions hold shares of Bioatla Inc, with a combined market value of approximately 326.93K, accounting for 19.70% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -393050.00.